DUPILUMAB REDUCES CORTICOSTEROID USE IN CHILDREN WITH UNCONTROLLED MODERATE -TO -SEVERE ASTHMA REGARDLESS OF EXACERBATION HISTORY

被引：0
|
作者：
Ducharme, F.
Sher, L.
Hamelmann, E.
de Mir, I.
Xia, C.
Gall, R.
Ledanois, O.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P118
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
    Busse, William W.
    Maspero, Jorge F.
    Hanania, Nicola A.
    Fitz-Gerald, J. Mark
    Ford, Linda B.
    Rice, Megan
    Lu, Yufang
    Rowe, Paul
    Staudinger, Heribert
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB97 - AB97
  • [42] DUPILUMAB IN MODERATE-TO-SEVERE ASTHMA: GOOD OUTCOMES IN CHILDREN
    Nuttall, Amy G.
    THORAX, 2022, 77 (04) : 424 - 424
  • [43] DUPILUMAB REDUCES RISK OF SEVERE EXACERBATIONS AND IMPROVES FEV1 REGARDLESS OF BASELINE DISEASE SEVERITY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Papi, A.
    Wenzel, S.
    Park, H. S.
    Rice, M.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A48 - A48
  • [44] DUPILUMAB REDUCES SEVERE OUTPATIENT ASTHMA EXACERBATIONS, CUMULATIVE DOSE, AND TOTAL NUMBER OF DAYS OF SYSTEMIC CORTICOSTEROID USE AMONG PATIENTS WITH MODERATE-TO-SEVERE TYPE-2 ASTHMA
    Canonica, Giorgio Walter
    Zeiger, Robert
    Castro, Mario
    Msihid, Jerome
    Ortiz, Benjamin
    Pandit-Abid, Nami
    Kamat, Siddhesh
    Khan, Asif
    CHEST, 2020, 158 (04) : 1810A - 1812A
  • [45] REAL-WORLD REDUCTION OF ORAL CORTICOSTEROID USE IN PATIENTS TREATED WITH DUPILUMAB AND WITH MODERATE-TO-SEVERE ASTHMA
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. D. P.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [46] Dupilumab in moderate-to-severe asthma
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (01) : 209 - 209
  • [47] Dupilumab: A Review in Moderate to Severe Asthma
    Emma D. Deeks
    Drugs, 2019, 79 : 1885 - 1895
  • [48] Impact Of Exacerbation History On Dupilumab Efficacy In Children With Asthma In The VOYAGE Study
    Guilbert, Theresa
    Tolcachier, Alberto
    Fiocchi, Alessandro
    Katelaris, Constance
    Phipatanakul, Wanda
    Begin, Philippe
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB19 - AB19
  • [49] Dupilumab: A Review in Moderate to Severe Asthma
    Deeks, Emma D.
    DRUGS, 2019, 79 (17) : 1885 - 1895
  • [50] Dupilumab Provides Rapid and Sustained Exacerbation Protection in Patients with Uncontrolled, Moderate-to-Severe Type 2 Inflammatory Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Rogers, L.
    Papi, A.
    Chen, Z.
    Pandit-Abid, N.
    Rowe, P.
    Deniz, Y.
    Ortiz, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345